| INTRODUCTION
Polytopic membrane proteins are integrated into the endoplasmic reticulum (ER) membrane through a series of steps that include targeting of ribosome-nascent polypeptide complexes to the translocon and lateral partitioning of α-helical transmembrane spans into the lipid bilayer. This is followed by the chaperone-assisted folding of lumenal, cytosolic and membrane-embedded protein domains. 1 A subset of polytopic proteins additionally requires specialist membrane-associated chaperones to achieve their fully folded state. 2 These dedicated chaperones are highly heterogeneous and act on a limited number of client proteins. Some bind transmembrane helices as they exit the translocon, thereby preventing aggregation until the substrate has attained its final topology or oligomeric state. 3 Clientspecific chaperones can also promote ER exit by providing signals for interaction with the coat protein II (COPII) budding machinery and accompany their substrate out of the ER. These chaperones are retrieved to the ER in coat protein I (COPI) vesicles, or transported with their substrates to their final destination, where they may play additional roles.
Currently, little is known about the precise roles of substratespecific chaperones. Several dedicated molecular chaperones have been described in the yeast Saccharomyces cerevisiae. Loss of Shr3, Pho86, Gsf2 and Chs7 causes aggregation and ER retention of their cognate substrates Gap1, Pho84, Hxt1 and Chs3, respectively. 4 A systematic study in yeast uncovered substrates for other ER exit chaperones including Erv14, Erv29 and Erv26. 5 However, the mechanism by which each of these proteins promotes folding and ER exit of their substrates may differ. Neither Shr3 nor Pho86 leave the Abbreviations: BN-PAGE, blue-native polyacrylamide gel electrophoresis; CW, calcofluor white; DIC, differential interference contrast; ER, endoplasmic reticulum; GFP, green fluorescent protein; HA, hemagglutinin; kb, kilobase; kD, kiloDalton; mAb, monoclonal antibody; MVB, multi-vesicular body; OD 600 , optical density at 600 nm; ORF, open reading frame; PM, plasma membrane; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresis; SEM, standard error of the mean; TMD, transmembrane domain; UTR, untranslated region; YFP, yellow fluorescent protein ER. 6, 7 In contrast, both Gsf2 and Vma21, which is required for the functional assembly and export of V-ATPase, are exported from the ER with their substrates and have a KKXX signal that directs their COPI-mediated recycling back to the ER. 8, 9 Chs7 is required for the folding and ER exit of the yeast chitin synthase Chs3, but is not required for folding or transport of the 2 other chitin synthases, Chs1 and Chs2. 4, 10 Chs3 has additional requirements for folding and transport through the secretory FIGURE 1 Conserved residues in the C-terminal tail of Chs7 determine its localization and binding to Chs3. (A) Genomically-tagged Chs7-GFP and Chs3-GFP localized primarily to the bud neck and intracellular puncta in wild type cells, but were mislocalized in chs3Δ and chs7Δ mutants, respectively. Localization defects were rescued by expression of CHS3 or CHS7-HA from plasmids. (B) Schematic diagram of Chs7 topology and the mutations made to the Chs7 C-terminal domain. (C) Wild type and mutant forms of Chs7-GFP were integrated at the genomic locus and imaged by fluorescence microscopy. Top: representative images; Bottom: Automated image analysis at 2 different intensity thresholds was used to quantitate the total number of cells with bud neck localized Chs7-GFP and the number with bright bud neck localization. Error bars report SEM, ≥1339 cells/condition/replicate, n = 3. One-way ANOVA with a Dunnett-corrected post hoc test *P < .05, ****P < .0001. (D) Wild type and mutant forms of Chs7-GFP were immunoprecipitated with anti-GFP antibody and co-precipitating Chs3-HA was detected with anti-HA antibody. WCL, whole cell lysate. Scale bars = 2 μM pathway. Palmitoylation of Chs3 by the palmitoyl transferase Pfa4 is needed to prevent aggregation and partial retention of Chs3 in the ER. 11 At the Golgi, Chs3 is recognized by components of exomer, a specialized coat that regulates its export to the cell surface, [12] [13] [14] [15] [16] while other factors such as Chs4 and Bni4 contribute to Chs3 activation and retention at the bud neck. [17] [18] [19] Chs3 transits between the Golgi, bud neck, and endosomes in a cell-cycle dependent manner 13, 20 and is maintained in intracellular compartments until ready for use. 21 Here, we examine how Chs7 mediates folding and export of Chs3. We find that Chs7 is not an ER resident protein as was previously reported. Instead, Chs7 forms a complex with Chs3 and colocalizes with Chs3 at the cell surface and in Golgi/endosomal compartments. We show that Chs7 and Chs3 depend on each other for proper trafficking and that Chs3 requires Chs7 to function as a chitin synthase. This suggests that Chs7 is not only a Chs3-specific folding chaperone and ER exit factor, but functions as a cofactor to regulate the enzymatic activity of Chs3 at the cell surface.
2 | RESULTS
| Chs7 localizes to the cell surface and intracellular structures
A previous report suggested Chs7 is an ER resident protein. 10 However, we found that when Chs7-GFP (green fluorescent protein) was tagged at its chromosomal location it was not found in the ER at steady state but instead was present at the bud neck and intracellular puncta ( Figure 1A ), as described in high-throughput studies. 22, 23 The previously reported ER localization of Chs7 was based on the distribution of a plasmid-expressed tagged protein. 10 Strains containing this plasmid exhibited much higher levels of Chs7-GFP relative to strains expressing Chs7-GFP its endogenous locus ( Figure S1A , Supporting information), suggesting that the ER localization could be an overexpression artifact. Addition of upstream sequences to the plasmid-borne CHS7 reduced expression levels and restored localization to the bud neck and intracellular puncta ( Figure S1A ,B).
The distribution of Chs7-GFP was strikingly similar to Chs3-GFP ( Figure 1A ), although we were unable to compare the co-localization of Chs7 and Chs3 directly because of the low signal of our RFPtagged proteins. In strains lacking Chs3, Chs7 was no longer seen at the bud neck or intracellular puncta, but instead was present in the ER and vacuoles ( Figure 1A ). It is unlikely that the ER pool of Chs7 is retained in the ER by COPI-mediated retrieval, as its localization was unchanged in a sec21-1 mutant 24 ( Figure S1C ). While the ER exit of Chs7 appears to be partially defective in chs3Δ mutants, the prominent vacuolar localization indicates that a substantial proportion of Chs7 is able to exit the ER. In contrast, Chs3 shows a strong ER localization in chs7Δ mutants, with no detectable vacuole or plasma membrane (PM) pool ( Figure 1A ), suggesting it is unable to exit the ER when Chs7 is not present. Thus, Chs7 does not entirely rely on Chs3 association for its ER exit, but does require Chs3 for its subsequent trafficking and steady-state localization to the bud neck and intracellular structures.
2.2 | Conserved residues in the Chs7 C-terminal tail contribute to Chs3 binding Chs7 is predicted to have 7 membrane-spanning domains, with an extracellular N-terminus, several short cytoplasmic loops, and a Cterminal tail. The C-terminal tail contains a conserved region from 287 to 301, which includes a predicted di-acidic COPII binding motif DxE (DLE) ( Figure S2 ). To determine if the Chs7 C-terminal tail contains elements critical for ER exit, we made a series of GFP-tagged truncation mutants at the endogenous CHS7 locus ( Figure 1B ). While deletion of the C-terminal 11 amino acids had little effect, removal of the last 14 or 17 residues (Chs7
Δ14
; Chs7 Δ17 ) reduced the intensity of the Chs7-GFP signal at bud necks ( Figure 1C ). Deletion of additional residues (Chs7
Δ20
; Chs7
Δ22
) resulted in a complete loss of bud neck localization and mislocalization to the ER. Figure 1C ). The DxE motif may be one of the several redundant exit signals present in the Chs7 C-terminal tail.
Alternatively, the DxE sequence could contribute to the folding or function of a larger conserved region that is important for the transport of Chs7 to the bud neck. We mutated highly conserved residues in this region to alanine, creating Chs7 LEF -GFP and Chs7
T293A
-GFP ( Figure 1B ).
Both mutants showed limited bud neck localization and enhanced vacuolar accumulation, similar to the Chs7 DxDxE -GFP mutant ( Figure 1C ).
Taken together, these results suggest that the conserved region of the Chs7 tail is not required for export in COPII vesicles, but instead is important for a post-ER trafficking step.
The localization of the most severely truncated forms of Chs7 was similar to that of wild type Chs7 in a strain lacking Chs3 ( Figure 1A ), suggesting these mutations might perturb the ability of Chs7 to recognize Chs3. Immunoprecipitation of wild type Chs7-GFP resulted in efficient co-purification of Chs3-HA (hemagglutinin) ( Figure 1D ). Chs7 point mutations greatly impaired the Chs3-Chs7 interaction, while the Δ22 truncation reduced Chs3 binding to background levels. This indicates that the conserved region of the Chs7 C-terminal tail is important for the interaction between Chs7 and Chs3.
| Mutation of conserved residues in the Chs7 C-terminal tail uncouples post-Golgi trafficking of Chs7 and Chs3
We next examined the localization of Chs3-GFP in strains containing chromosomally integrated, mutant forms of Chs7. In cells expressing the Chs7 Δ22 mutant, Chs3-GFP was partially retained in the ER (~40% of cells) ( Figure 2A ). Unexpectedly, expression of Chs7 mutants (Chs7 LEF , Chs7 T293A ) that exhibit strong vacuole accumulation had little effect on the steady-state localization of Chs3-GFP, which maintained a nearly wild type distribution at the bud neck (~20%-30% of cells) and in intracellular puncta (~30%-40% of cells) with relatively little ER retention. That Chs3 is largely able to exit the ER in these strains suggests the Chs7 LEF and Chs7 T293A mutations do not affect Chs3-Chs7 interactions at the ER or prevent entry into COPII vesicles, but instead cause Chs3 and Chs7 trafficking to diverge after ER exit.
We used strains carrying mutations in different transport steps to examine the trafficking itineraries of Chs3 and variant forms of Chs7. Chs3 has sorting signals for binding AP-1, retromer and exomer, and is retained intracellularly in exomer mutants by continuous AP-1-dependent cycling between Golgi and endosomes. [25] [26] [27] [28] In chs6Δ mutants, Chs7-GFP was trapped in intracellular Golgi/ endosomal compartments, but was sorted to the vacuole when the Chs3 interaction was abrogated by mutation of the Chs7 tail ( Figure 2B ). In contrast, Chs3-GFP was present in intracellular puncta in exomer mutants even in cells expressing Chs7 LEF and Chs7
T293A
( Figure 2B ). Thus, it appears that Chs3 does not require Chs7 for its normal post-Golgi sorting itinerary, whereas Chs7 relies on its association with Chs3 for recycling through the AP-1-dependent Golgi/ endosomal pathway.
The different localization of Chs3-GFP and the Chs7-GFP point mutants in chs6Δ cells suggests their trafficking diverges after transiting the Golgi. We found that deletion of the endosomal syntaxin Pep12
( Figure 2C ), which inhibits fusion of post-Golgi and endocytic vesicles with the late endosome, 29 blocked the vacuolar accumulation of with Chs3 is critical for Chs7 to recycle between Golgi and endosomes, and for its efficient transport to the cell surface. In contrast, Chs7 is absolutely required for Chs3 to exit the ER, but its continued association is largely dispensable for the post-ER trafficking of Chs3.
| Mutations that reduce Chs3-Chs7 complex formation do not cause aggregation
In the absence of Chs7, Chs3 forms aggregates that are retained in the ER. 4, 10, 11 To examine how Chs7 mutants that fail to associate with Chs3 after ER exit affect Chs3 folding, digitonin extracts prepared from cells co-expressing Chs3-GFP and wild type and mutant forms of Chs7-HA were resolved by blue-native polyacrylamide gel electrophoresis (BN-PAGE; Figure 3A ). In wild type cells, Chs3-GFP migrated as a single species consistent with the presence of a large Chs3 oligomer, 31, 32 although the exact molecular mass of membrane proteins is difficult to estimate by this technique because of the presence of bound lipids, detergents and dyes. 33 In contrast, Chs3-GFP extracted from chs7Δ cells was present in a high molecular weight smear and as a faster-migrating species that may represent different folding states or interactions with ER proteins. Truncation of the Chs7 tail (Chs7
Δ22
) resulted in a minor but reproducible increase in the faster-migrating form of Chs3-GFP and high molecular weight smear, while no aggregation was seen in strains expressing the Chs7 LEF and Chs7 T293A point mutants ( Figure 3A ). These results suggest that post-ER interactions with Chs7 are not required to prevent Chs3 aggregation.
To assess the extent of Chs3-Chs7 complex formation in these strains, parallel samples resolved by BN-PAGE were quantified by densitometry to create superimposed intensity profiles ( Figure 3B ,C).
In wild type cells Chs3-GFP was present in a single peak whereas Chs7-HA was found in 2 pools: a major pool that co-migrated with
Chs3-GFP and a minor faster-migrating species. The major comigrating pool of Chs7-HA was lost when CHS3 was deleted Chs3-HA surface levels were slightly reduced in strains expressing the chs7 point mutants (16% of total Chs3). In contrast, in strains expressing the chs7-Δ22 truncation mutant, which caused ER retention of Chs3, the amount of Chs3-HA present on the cell surface was only slightly greater than that of a chs7 null mutant.
To determine if the absence of Chs7 at the cell surface affects the enzymatic activity of Chs3, we grew strains on media containing the fluorescent antifungal compound calcofluor white (CW), which inhibits the growth of wild type cells by binding cell wall chitin.
11,34
While cells expressing wild type Chs7-GFP were sensitive to CW, all The proportion of Chs3-HA at the cell surface was determined by a protease accessibility assay in strains expressing the indicated wild type and mutant forms of Chs7-GFP. Half the cells from log phase cultures were treated with 2 mg/mL of pronase enzyme (+ protease) and the other half with buffer (− protease). Cell lysates were separated on SDS-PAGE and subjected to immunoblotting with an α-HA antibody. * indicates the position of the Chs3-HA fragment generated by pronase cleavage. A representative image is shown. (C) Quantitation of the protease accessibility assay shown in (B), shows the mean fraction of Chs3-HA cleaved by protease in 3 independent experiments. Error bars report SEM, n = 3. One-way ANOVA with a Dunnett-corrected post hoc test ** P < .01, **** P < 0.0001. (D) CW sensitivity was assessed in mutants expressing wild type and mutant forms of Chs7. Yeast were spotted in ×10 dilution series and grown on YPD with CW (150 μg/mL), or DMSO for 2 days at 30 C. (E) Relative chitin levels of the indicated strains were measured on yeast colony arrays grown on YPD media containing 50 μg/mL CW. Chitin-bound CW was quantified by densitometry of fluorescence images; error bars report SEM, n = 3. One-way ANOVA with a Dunnett-corrected post hoc test **** P < .0001; A.U., arbitrary units 3 chs7 tail mutants showed resistance similar to that of chs3Δ and chs7Δ mutants, suggesting that chitin production is reduced ( Figure 4D ).
For a more quantitative measure of chitin levels, we used an assay that measures CW fluorescence in colony arrays. 11, 34 As expected, the strains with the lowest fluorescence values included chs3 and chs7 null mutants ( Figure 4E ). Chitin levels in strains expressing the chs7-Δ22 truncation were not significantly higher than in chs3Δ or chs7Δ mutants, consistent with the low level of Chs3 present at the cell surface in these strains. Remarkably, strains expressing the chs7-LEF and chs7-T293A tail mutants also had very low chitin levels, despite the presence of Chs3 at the cell surface (Figures 4C). Similar results were obtained when a fluorescence imaging assay was used to quantitate chitin at bud necks and bud scars ( Figure S4A ). This suggests that lack of Chs7 at the cell surface does not strongly impact Chs3 transport and retention at the PM, but instead causes a dramatic reduction in the enzymatic activity of Chs3.
| Restoring the Chs7-Chs3 interaction rescues ER exit and post-Golgi trafficking
Our results suggest that dissociation of Chs3-Chs7 complexes is responsible both for missorting Chs7 at the Golgi and for the reduced 
Δ22
-YFP C exhibited punctate and bud neck fluorescence that was distinct from the ER and vacuolar localization of GFP-tagged Chs7 Δ22 (P < .01), and similar to that of wild-type Chs7-GFP ( Figure 5A,B) . This supports the model that Chs7 Δ22 fails to bind Chs3 efficiently, and that reinforcing this association rescues the ER exit and post-Golgi trafficking of both proteins.
To determine if rescue of the Chs3-Chs7 interaction also restores catalytic activity, we used CW fluorescence assays to estimate chitin levels in strains where these proteins are tagged either with YFP N and YFP C , or with HA and GFP ( Figures 5C and S4B) . We found cells expressing Chs7 Δ22 -GFP had a low level of chitin similar to cells lacking Chs3 ( Figure 5C ). Co-expression of Chs3-YFP N and Chs7
-YFP C significantly restored chitin production as measured by the colonybased CW fluorescence assay, and this rescue was even greater when the imaging assay was used to quantitate chitin at bud necks and bud scars ( Figure S4B ). Interestingly, fusion of split YFP tags to wild type forms of Chs3 and Chs7 reproducibly resulted in a slight but significant enhancement of Chs3 activity ( Figure 5C ). Taken together, this
indicates that the interaction between Chs7 and Chs3 is critical for
Chs3 activity at the cell surface, and suggests that modulation of this interaction could represent a mechanism for regulating chitin production in wild type cells ( Figure 6 ). We found that conserved residues in the Chs7 cytosolic domain were important for formation of a stable Chs3-Chs7 complex but were largely dispensable for Chs3 folding and ER exit. Cytosolic regions of the dedicated chaperone Shr3 are also unnecessary for folding and ER export of the Gap1 permease. 4 Instead, Shr3 transmembrane regions interact with the first 5 transmembrane domains (TMDs) of Gap1 to prevent aggregation and promote their association with the remaining TMDs. 36 Chs3 is predicted to contain 2 groups of TMDs separated by a large cytosolic catalytic domain. By analogy to Shr3, the Chs7 transmembrane portion may bind and stabilize one or more TMDs of Chs3. Full assembly would presumably require rearrangement and release of the TMDs, such that continued Chs3-Chs7 interaction would depend on residues in the Chs7 cytosolic domain. This model predicts that different Chs3-Chs7 interfaces mediate folding and post-ER association, and could explain why Chs7 cytosolic domain mutations did not prevent folding, but instead reduced Chs3-Chs7 interactions at subsequent transport steps.
Whereas some dedicated chaperones, including Shr3, are restricted to the ER, others are transported in COPII vesicles with their substrates and may provide signals needed for ER exit. 37, 38 Although mutation of a putative diacidic COPII binding motif in the Chs7 tail did not block ER exit, Chs7 could direct the Chs3-Chs7 complex into COPII vesicles using redundant motifs, which could take many forms (eg, DxE, FF, LL, VV, IXM, LXXLE, ΦXΦXΦ, RI/RL). 39 Other proteins could also direct sorting into COPII vesicles. For example, Erv14 was proposed to facilitate the ER exit of Chs3. 31 Alternatively, Chs3 could have ER export signals that depend on its conformational state or are masked by Chs3 aggregation, and thus are only recognized when Chs7 is present. Further work will be needed to define the determinants responsible for the ER exit of Chs3.
Chs7 does not absolutely require Chs3 for its ER exit, yet strongly depends on its association with Chs3 for subsequent trafficking steps ( Figure 6 ). Exomer-dependent transport of Chs7 was observed only when it was bound to Chs3, suggesting Chs7 relies on Chs3 to provide sorting signals 15, 16, 25, 28 that direct its own trafficking itinerary. When not stably associated with Chs3, Chs7 was largely transported to the vacuole via the late endosome/multi-vesicular body (MVB). This caused a dramatic reduction in chitin levels, though
Chs3 was not aggregated and appeared to maintain nearly wild type localization at endosomes and the cell surface.
Several different models could account for the influence of Chs7 on Chs3 activity. First, Chs7 sequences could form an integral part of the catalytic site. However, Chs7 is not needed for chitin synthesis by Chs1 or Chs2, 2 synthases with related catalytic domains. Alternatively, the presence of Chs7 could help Chs3 to maintain its fully active conformation or promote its association with activators such as Chs4. 19 A final hypothesis is that Chs7 is not an obligatory subunit of a Chs7-Chs3 chitin synthase complex, but instead interacts reversibly with Chs3 to regulate its activity. Chs7 is a 7-TMD protein with a large, conserved extracellular domain that could sense and respond to extracellular signals by activating Chs3.
Because dissociation of Chs7 and Chs3 did not cause gross misfolding of Chs3, and manipulations designed to stabilize Chs3/Chs7 interactions slightly enhanced Chs3 activity, it is tempting to speculate that the Chs3/Chs7 interaction is dynamic and regulated in response to extracellular signals.
Chs3 belongs to the GT-2 family of integral membrane processive glycosyltransferases that includes human hyaluronan synthase, which is involved in extracellular matrix formation, and plant cellulose synthase. 40, 41 Because other members of the GT-2 family require accessory factors, future studies to characterize how Chs7 impacts
Chs3 function may contribute to our general understanding of this important enzyme family. 
| Strains, plasmids and media
General molecular biology methods were as described. 42, 43 Strains and plasmids used in this study are listed in Tables S1 and S2 . Open reading frames (ORFs) were genomically tagged with sequences encoding HA, GFP or an improved version of GFP (GFP+) by PCRbased homologous recombination. [44] [45] [46] nat R (Nourseothricin resistance) and hph R (Hygromycin B resistance) knockout strains were created by PCR-based homologous recombination using gene-specific primers to amplify drug resistance cassettes from p4339 (nat R MX4) 47 or pFA6-hphNT1. 48 Knockout strains were confirmed by PCR of genomic DNA. The plasmids pTM15 and pTM16 were a gift from C. Roncero. 
| Co-immunoprecipitations
Co-immunoprecipitation was performed as previously described. 11, 44 Briefly, 20 optical density at 600 nm (OD 600 ) of spheroplasts were resuspended in 1 mL lysis buffer containing 1% CHAPSO, 50 mM 
| Protease accessibility
The protease accessibility assay was modified from References 49 and 50 . Five OD 600 of log phase cells expressing Chs3-3xHA were harvested and washed in 1 mL Pronase buffer (PB, 1.4 M sorbitol, 25 mM Tris-HCl of pH 7.5, 10 mM NaN 3 , 10 mM NaF). Cells were resuspended in 350 μL PB and incubated for 30 minutes at 30 C.
Half was treated with a final concentration of 2 mg/mL Pronase (Calbiochem-Novabiochem) at 37 C for 1 hour and the other half was mock treated with an equal volume of PB. Cells were collected at 6500 rpm, resuspended in 225 μL PB, and proteins were precipitated with 50 μL of 100% trichloroacetic acid (TCA 
| Calcofluor white growth assay
One OD 600 of log phase yeast grown in YPD medium was spotted in ×10 serial dilution on plates containing 150 μg/mL CW (Sigma) or dimethyl sulphoxide (DMSO) and incubated at 30 C for 2 days. Plates were imaged using a Canon Rebel T3I camera (Canon Inc.).
| Calcofluor white colony array fluorescence assay
Source arrays were created by randomly placing each strain at 12 different positions of a 96-density array on a YPD plate. A BM5 pinning robot (S&P Robotics) was used to pin source arrays at 1536 density to YPD plates containing 50 μg/mL CW, which were incubated in light-proof containers at 30 C for 3 days. White-light images were acquired using a Canon EOS Rebel 3Ti camera, and fluorescence images were captured with a PXi 9 Touch multi-imager (Syngene) using EPI MW (302 nm) Ultraviolet illumination and the 516 to 539-nm emission filter. An in-house spot-finding program was used for densitometry of digital images. Average growth and fluorescence values were calculated for each strain using Microsoft Excel; slow growing strains were removed from the analysis.
| Fluorescence microscopy
Live cells expressing GFP or YFP fusions were grown to log phase at Figures S1 and S3 where cells were viewed using a ×100 oil-immersion objective on a Zeiss Axioplan2 fluorescence microscope (Thornwood), and images were captured with a CoolSnap camera using MetaMorph software (Universal Imaging).
| Automated analysis of bud neck localization
Image analysis was carried out using custom MetaMorph 7.7 journals.
To Chitin levels at bud necks and bud scars were quantified from images of cells grown overnight in YPD medium containing 5 μg/mL CW. Live cells were identified and counted using the Count Nuclei application, whereas the Granularity application was used to measure the intensity of bright CW-stained structures corresponding to bud scars.
| Sequence alignments
Homologous sequences were aligned using MUSCLE 51 and viewed using JALVIEW. 
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